Skip to main content

Table 4 Clinical features of 50 cases of ALK-DLBCL reported in the literature

From: ALK-positive diffuse large B-cell lymphoma: report of four cases and review of the literature

Ā 

N

%/range

Age, years (n = 47)

38

9 ā€“ 72

Sex (n = 50)

Ā Ā 

ā€ƒā€ƒā€ƒMale

38

76

ā€ƒā€ƒā€ƒFemale

12

24

Site of involvement (n = 46)

Ā Ā 

Exclusively nodal

24

52

ā€ƒā€ƒā€ƒCervical

17

71

ā€ƒā€ƒā€ƒOther

7

29

Extranodal

22

48

ā€ƒā€ƒā€ƒBone

8

36

ā€ƒā€ƒā€ƒLiver and spleen

4

18

ā€ƒā€ƒā€ƒHead and neck

3

14

ā€ƒā€ƒā€ƒGastrointestinal tract

3

14

ā€ƒā€ƒā€ƒOther*

8

36

Clinical stage (n = 47)

Ā Ā 

ā€ƒā€ƒā€ƒI ā€“ II

20

43

ā€ƒā€ƒā€ƒIII ā€“ IV

27

57

Therapy (n = 41)

Ā Ā 

ā€ƒā€ƒā€ƒChemotherapy

34

83

ā€ƒā€ƒā€ƒChemoradiotherapy

6

15

ā€ƒā€ƒā€ƒRadiotherapy

1

2

Relapsed cases

18

44

Salvage HSCT

8

20

Survival time, months (n = 36)

24

3 ā€“ 156

  1. HSCT ā€“ hematopoietic stem cell transplantation
  2. *Includes bone marrow, CNS, gonads and muscle